Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages

x

This content is available also in other languages

November 18, 2014 | Customer News

Simplifying SPR experiments with the HP D300 from Tecan

November 18, 2014

Simplifying SPR experiments with the HP D300
from Tecan

Stefan Geschwindner with the HP D300

Männedorf, Switzerland, November 18, 2014 – The Structure and Biophysics department at AstraZeneca R&D Mölndal, Sweden, is reaping the benefits of a recently acquired HP D300 Digital Dispenser for surface plasmon resonance (SPR) studies, saving time, enhancing consistency and using significantly less compound for dose-response experiments. Principal Scientist Stefan Geschwindner explained: “The need for the HP D300 Digital Dispenser was largely driven by a demand for more effective SPR studies and increased flexibility. We already had an acoustic dispenser, but this was not ideal, as there are peaks and troughs in our work, and we needed an economical solution that could accommodate these changing demands. Tecan provided an instrument for us to try, and people immediately saw the benefits, realizing that the HP D300 could really change our way of working, helping to generate data more rapidly and shorten lead times.”

“The HP D300 is very easy to use and saves us so much time. It gives us the flexibility to use very low concentration stock solutions and perform different dilution patterns, and the instrument does all the calculations for us. Another big advantage is that we save a lot of material, which is particularly important when the amount of compound available is limited. The HP D300 can even recover any solution that has not been dispensed, which is brilliant. The savings are tremendous and, other than manual pipetting, this is probably the only effective way to prepare our dose-response curves.”

To find out more about the HP D300 Digital Dispenser, visit www.tecan.com/digitaltitration
 

 
For more information please contact

Tecan Trading AG
Cornelia Kegele, Antonietta Allocca
Seestrasse 103
CH-8708 Männedorf

Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12

info@tecan.com
www.tecan.com

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2013, Tecan generated sales of CHF 388 million (USD 419 million; EUR 316 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).